|
|
|
Insider
Information: |
Haller Julia A |
Relationship: |
|
City: |
Summit |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
44,027 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$591,988 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
44,027 |
|
|
Total
Value |
$591,988 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Celgene Corp |
CELG |
|
2019-11-20 |
0 |
|
0 |
Premium* |
|
Bristol-Myers Squibb Co |
BMY |
Director |
2022-06-03 |
13,619 |
2020-06-03 |
0 |
Premium* |
|
Eyenovia Inc |
EYEN |
|
2022-06-16 |
30,408 |
2021-03-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CELG |
Celgene Corp |
Director |
|
2015-10-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
200 |
|
- |
|
CELG |
Celgene Corp |
Director |
|
2017-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
375 |
575 |
0 |
- |
|
CELG |
Celgene Corp |
|
|
2018-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
300 |
875 |
0 |
- |
|
CELG |
Celgene Corp |
|
|
2018-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
375 |
1,250 |
0 |
- |
|
CELG |
Celgene Corp |
|
|
2019-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
484 |
1,734 |
0 |
- |
|
CELG |
Celgene Corp |
|
|
2019-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
300 |
2,034 |
0 |
- |
|
CELG |
Celgene Corp |
|
|
2019-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
375 |
2,409 |
0 |
- |
|
CELG |
Celgene Corp |
|
|
2019-11-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,409) |
0 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Director |
|
2020-06-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,949 |
5,358 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Director |
|
2020-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
903 |
6,261 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Director |
|
2020-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
558 |
6,819 |
0 |
- |
|
EYEN |
Eyenovia Inc |
Director |
|
2021-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,223 |
1,223 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Director |
|
2021-06-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,949 |
9,768 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Director |
|
2021-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
902 |
10,670 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Director |
|
2022-06-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,949 |
13,619 |
0 |
- |
|
EYEN |
Eyenovia Inc |
|
|
2022-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
22,222 |
30,408 |
0 |
- |
|
16 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|